Join to view full profile
530 S Jackson StLouisville, KY 40202
Phone+1 502-562-3000
Dr. Goldsberry is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Gynecologic Oncology, 2018 - 2021
University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 2014 - 2018- University of Louisville School of MedicineClass of 2014
Certifications & Licensure
IN State Medical License 2022 - 2027
KY State Medical License 2021 - 2027
AL State Medical License 2018 - 2021
MS State Medical License 2019 - 2021
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Anti--methyl-d-aspartate (NMDA) receptor encephalitis associated with mature ovarian teratoma: a case report.Aaron Adams, Elizabeth Farabee, Chelsae Nugent, Whitney Goldsberry
Case Reports in Women's Health. 2026-12-01 - Lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia initially presenting as postmenopausal pelvic pain and bleeding: a rare case report with literature review.Mackenzie Dent, Mustafa Al-Kawaaz, Kadam Maruthi, Jenci Hawthorne, Whitney Goldsberry
Gynecologic Oncology Reports. 2026-04-01 - 1 citationsBilateral adnexal masses: A case report of acute myeloid leukemia presenting with myeloid sarcoma of the ovary and review of literature.Jenci Hawthorne, Hajrunisa Cubro, Elizabeth Farabee, Samer Z Al-Quran, Mustafa Al-Kawaaz
Gynecologic Oncology Reports. 2023-06-01
Grant Support
- A novel combination therapy for recurrent ovarian cancerUNIVERSITY OF LOUISVILLE2026–2028
- A novel combination therapy for recurrent ovarian cancerUNIVERSITY OF LOUISVILLE2026–2028
- A novel combination therapy for recurrent ovarian cancerUNIVERSITY OF LOUISVILLE2026–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
